Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Feb;94(2):163-6.
doi: 10.3324/haematol.2008.002766.

Changing paradigms in the treatment of multiple myeloma

Joan Bladé, Laura Rosiñol
Review

Changing paradigms in the treatment of multiple myeloma

Joan Bladé et al. Haematologica. 2009 Feb.

Abstract

The outcome of patients with multiple myeloma treated with conventional approaches has been unsatisfactory. In this perspective article, Drs. Bladé and Rosiñol examine the novel therapeutic options and their impact on the survival of these patients. See related paper on page 270.

PubMed Disclaimer

Comment on

References

    1. Bladé J, Rosiñol L. Advances in therapy of multiple myeloma. Curr Opin Oncol. 2008;20:697–704. - PubMed
    1. Harousseau JL. Role of stem cell transplantation in multiple myeloma. Hematol Oncol Clin North Am. 2007;21:1157–74. - PubMed
    1. Rajkumar SV, Blood E, Vesole D, Fonseca R, Greipp PR Eastern Cooperative Oncology Group. Phase III trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed myeloma: a clinical trial coordinated by the Eastern Cooperative Group. J Clin Oncol. 2006;24:431–6. - PubMed
    1. Harousseau JL, Attal M, Leleu X, Troncy J, Pegourie B, Stoppa AM, et al. Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma. Haematologica. 2006;91:1498–505. - PubMed
    1. Rosiñol L, Oriol A, Mateos MV, Sureda A, García-Sánchez P, Gutiérrez N, et al. A phase II trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumour response kinetics. J Clin Oncol. 2007;25:4452–8. - PubMed

MeSH terms